Ads
related to: current treatment for hepatitis b- Hepatitis B Screening
Discover The Importance Of
Screening To Identify Hepatitis B
- Chronic Hep B Information
Understand Chronic Hep B & Find
Info On Screening For The Disease
- Clinical Resources
Access Clinical Education Resources
For HCPs Here
- Product Dosage Info
Find Dosage Information For A
Chronic Hep B Treatment Option
- Mechanism Of Action
Learn More About The MOA Of A
Chronic Hep B Treatment Option
- ALT Normalization Data
Find Stats About ALT Normalization
On A Chronic Hep B Treatment Option
- Hepatitis B Screening
Search results
Results From The WOW.Com Content Network
820,000 resulting from hepatitis B (2019) [1] Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that affects the liver; [1][6] it is a type of viral hepatitis. [7] It can cause both acute and chronic infection. [1] Many people have no symptoms during an initial infection. For others, symptoms may appear 30 to 180 days ...
Hepatitis B vaccine. Hepatitis B vaccine is a vaccine that prevents hepatitis B. [13] The first dose is recommended within 24 hours of birth with either two or three more doses given after that. [13] This includes those with poor immune function such as from HIV/AIDS and those born premature. [13]
Hepatitis B virus is classified in the genus Orthohepadnavirus, which contains 11 other species. [3] The genus is classified as part of the Hepadnaviridae family, which contains four other genera, Avihepadnavirus, Herpetohepadnavirus, Metahepadnavirus and Parahepadnavirus. [3] This family of viruses is the only member of the viral order ...
Adefovir dipivoxil. Adefovir works by blocking reverse transcriptase, an enzyme crucial for the HBV to reproduce in the body.It is approved for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (primarily ALT) or histologically active disease.
The Hepatitis B Foundation. The Hepatitis B Foundation (HBF) is an American nonprofit organization dedicated to finding a cure for hepatitis B and improving the lives of those already affected by the disease. Established in 1991, the foundation's headquarters is in Doylestown, Pa. [1] It is the world's only nonprofit focused solely on hepatitis ...
Entecavir. Entecavir, sold under the brand name Baraclude, is an antiviral medication used in the treatment of hepatitis B virus infection. [6] In those with both HIV/AIDS and hepatitis B virus antiretroviral medication should also be used. [6] Entecavir is taken by mouth as a tablet or solution. [6]
Telbivudine. Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (European Union) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause ...
HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen. It is extracted from the Cohn fraction II. During the process, viruses are deactivated, and in the final steps, solvents used in the preparation are removed. The preparation is tested for absence of HIV, HCV, herpes virus, and reovirus.
Ads
related to: current treatment for hepatitis b